Applications of 4-Morpholinophenylboronic Acid in Industrial Manufacturing

4-Morpholinophenylboronic Acid serves key roles across advanced pharmaceutical, agrochemical, specialty electronics, and analytical reagent manufacturing. As a direct manufacturer, we address stringent industry requirements through controlled synthesis and quality management. The following application scenarios specify downstream integration, compliance, usage ratios, and end products for industrial customers.

1. Pharmaceutical Intermediate for Kinase Inhibitor Synthesis

Pharmaceutical manufacturers utilize this boronic acid as a unique intermediate in the Suzuki-Miyaura cross-coupling to construct biaryl motifs present in multiple kinase inhibitor APIs, especially for oncology. During drug substance development, its inclusion enables direct installation into complex heterocyclic systems, notably for morpholine-substituted aryl fragments crucial in active small-molecule pharmaceuticals. Manufacturing adaptation requires careful management of reaction stoichiometry, moisture sensitivity, and robust in-process controls. Batch records reference the inclusion timing to ensure regulatory traceability and downstream product consistency.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• 21 CFR 211: US FDA cGMP for Finished Pharmaceuticals
• European Pharmacopoeia General Methods (Ph. Eur. 2.9.13, 2.3.2)
• Chinese Pharmacopoeia (for clinical trial or domestic registration, where applicable)

Typical usage ratio

• 0.8 to 1.2 molar equivalents per cross-coupling reaction, adjusted according to targeted API structure and desired yield

Downstream process integration

• Incorporation during palladium-catalyzed Suzuki coupling step after base formation and prior to quench or isolation
• Followed by solvent switch, product isolation, and API purification stages

Final product types

• Oral or injectable cancer therapeutics (kinase inhibitors such as PI3K, ALK, or Bcr-Abl inhibitors)
• Targeted molecular therapies in late-stage clinical or commercial scale

2. Key Building Block in Agrochemical Synthesis

Major agrochemical firms select this compound for the formation of aryl-boron frameworks essential to developing next-generation fungicides and herbicides. During process development, chemists leverage its efficiency in C–C coupling reactions, enhancing yields of high-value, structure-specific crop protection agents. The material must confer consistent reactivity and meet impurity control expectations, particularly regarding boron and nitrogen-containing by-products. Documentation and segregation ensure downstream traceability from raw material intake to formulation tanks.

Industry compliance standards

• ISO 9001:2015 certified Quality Management System (agrochemical manufacturing)
• FAO/WHO Good Laboratory Practice (GLP) for chemical inputs
• REACH Regulation (EC) No 1907/2006 (substance registration and safety checks)
• Relevant national pesticide registration requirements (e.g., US EPA, EU REG 1107/2009)

Typical usage ratio

• 0.9 to 1.1 molar equivalents, fine-tuned based on the target fungicide or herbicide active and process scale

Downstream process integration

• Dosed during stepwise coupling for aryl or heteroaryl formation in active ingredient synthesis
• Post-coupling purification and formulation as solid or liquid concentrates

Final product types

• Protective seed coatings
• Pre- and post-emergent herbicide granules
• Fungicidal sprayable concentrates for large-scale crop protection

3. Electronic Chemicals – Organic Semiconductor Precursor

Producers of organic semiconductors and optoelectronic materials use this raw material for the synthesis of π-conjugated systems and functionalized polymers in OLEDs and OFETs. The presence of morpholine and boronic acid substituents promotes tunability of charge transport and photophysical properties. Stringent process controls including moisture exclusion, trace metal analysis, and reactor cleanliness support defect-free device manufacturing. Batch homogeneity and purity impact downstream defect rates and reproducibility in electronic applications.

Industry compliance standards

• IEC 60747-1: General rules for semiconductor devices
• RoHS Directive 2011/65/EU (control of restricted substances)
• JIS C 5016 (electronic chemical purity standards for Japan market)
• ISO 14644-1: Cleanroom and controlled environment requirements

Typical usage ratio

• 1.0 to 1.3 equivalents per functional group introduced, depending on molecular design and application target

Downstream process integration

• Introduced during monomer synthesis for arylation steps
• Follows with polymerization, purification, and thin-film deposition

Final product types

• Active organic semiconducting layers (OLED, OPV, OTFT)
• LED display components
• Sensor array materials (chemical/biological sensors)

4. Analytical Chemistry – Reagent for Derivatization and Quantitative Analysis

Contract research and QC labs adopt this boronic acid as a selective reagent for derivatization steps in HPLC, LC-MS, and bioanalytical testing of diols and saccharides. Lab protocols employ its morpholine functionality for improved aqueous solubility and greater selectivity in molecular labeling, crucial for trace-level quantification. The compound enters derivatization kits, custom reference materials, and stability-indicating method development. Strict batch QC and documentation underpin its role in validated analytical procedures aligned with regulated environments.

Industry compliance standards

• USP <1225>: Validation of Compendial Procedures
• GLP compliance for reference standard preparation
• ISO/IEC 17025: Testing and calibration laboratory accreditation
• OECD Guidelines for the Testing of Chemicals (analytical use)

Typical usage ratio

• 10 to 100 μM concentration range per sample, calibrated empirically to target analyte levels and method sensitivity

Downstream process integration

• Added to reaction vessel during sample pre-treatment or derivatization step before instrument analysis
• Integrated in standard curve preparations for method validation

Final product types

• Certified analytical derivatization kits
• Method validation standards for GMP and GLP test environments
• Bioanalytical quantification services